The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity.
A compound represented by the formula (I):
wherein each symbol is as described in the description, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.
The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity.
A compound represented by the formula (I):
wherein each symbol is as described in the description, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.
COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS
申请人:BIOGEN IDEC MA INC.
公开号:US20150203515A1
公开(公告)日:2015-07-23
Compounds of formula (I) can modulate the activity of one or more SIP receptors and/or the activity of autotaxin (ATX).
式(I)的化合物可以调节一个或多个SIP受体的活性和/或自体向素(ATX)的活性。
Juaristi, Eusebio; Lopez-Nunez, Norma A.; Valenzuela, Bertha A., Journal of Organic Chemistry, 1987, vol. 52, # 23, p. 5184 - 5189
作者:Juaristi, Eusebio、Lopez-Nunez, Norma A.、Valenzuela, Bertha A.、Valle, Lucia、Toscano, Ruben A.、Soriano-Garcia, Manuel
DOI:——
日期:——
US9550798B2
申请人:——
公开号:US9550798B2
公开(公告)日:2017-01-24
US9944666B2
申请人:——
公开号:US9944666B2
公开(公告)日:2018-04-17
[EN] COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS<br/>[FR] COMPOSÉS ÉTANT DES AGENTS DE MODULATION DE S1P ET/OU DES AGENTS DE MODULATION D'ATX
申请人:BIOGEN IDEC INC
公开号:WO2014018891A1
公开(公告)日:2014-01-30
Compounds of formula (I) can modulate the activity of one or more SIP receptors and/or the activity of autotaxin (ATX).